Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uta Eberlein

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2023
SUVPhilipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyKen Herrmann, Christina Bluemel, Martina Weineisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2024
Dosimetry and pharmacokinetics of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumoursSeval Beykan Schürrle, Uta Eberlein, Catherine Ansquer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD projectJan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
European Thyroid Journal|June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancerJan Taprogge, Iain Murray, Hannah Sharman, et al.
European Urology|September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate CancerDaniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2023
SUVPhilipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyKen Herrmann, Christina Bluemel, Martina Weineisen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2024
Dosimetry and pharmacokinetics of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumoursSeval Beykan Schürrle, Uta Eberlein, Catherine Ansquer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD projectJan Taprogge, Alex Vergara-Gil, Francesca Leek, et al.
European Thyroid Journal|June 18, 2025
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancerJan Taprogge, Iain Murray, Hannah Sharman, et al.
European Urology|September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate CancerDaniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
Pageof 5